Şunu aradınız:: bilirrubina directa (İspanyolca - İngilizce)

bilirrubina directa
bilirubin conjugated

bilirrubina directa anormal
direct bilirubin abnormal

plaquetas bilirrubina – directa
platelets bilirubin – direct bilirubin - indirect

medición de bilirrubina directa
bilirubin, direct measurement

bilirrubina, total y directa
bilirubin, total and direct

bilirrubina – directa bilirrubina – indirecta
bilirubin – indirect

bilirrubina total y bilirrubina directa.
total bilirubin and direct bilirubin.

medición de bilirrubina directa (procedimiento)
bilirubin, direct measurement

elevación de la bilirrubina directa > 2 x lsn
elevated direct bilirubin > 2 ×uln

hemoglobina leucocitos neutrófilos plaquetas bilirrubina – directa
if:

neutrófilos plaquetas bilirrubina ­ directa bilirrubina ­ indirecta
bilirubin ­ indirect

medición directa de bilirrubina
bilirubin, conjugated measurement

contraindicado en pacientes con elevación de la bilirrubina directa > 2 x lsn antes de iniciar el tratamiento
contraindication in patients with elevated direct bilirubin > 2 x uln prior to initiation of treatment.

acompañados de bilirrubina directa aumentada, o acompañados de síntomas de daño hepático o evidencia de descompensación hepática
accompanied by increased direct bilirubin, or accompanied by clinical symptoms of liver injury or evidence for hepatic decompensation.

leucocitos-1,5 x 109/l1,0 x 109/lneutrófilosplaquetas bilirrubina ­ directa bilirrubina ­ indirecta
four week period during treatment (permanent dose reduction) 1.5 x 109/l - 0.75 x 109/l - 50 x 109/l ---5 mg/dl -

la bilirrubina indirecta, que no se disuelve en agua, debe llegar hasta el hígado para convertirse en una forma soluble, bilirrubina directa.
indirect bilirubin, which doesn't dissolve in water, must travel to the liver to be changed into the soluble form, direct bilirubin.

estas elevaciones no se asociaron a un aumento clínicamente relevante de la bilirrubina directa, ni se asociaron a pruebas clínicas de hepatitis o deterioro hepático.
these elevations were not associated with clinically relevant increase in direct bilirubin, nor were they associated with clinical evidence of hepatitis or hepatic impairment.

estableel tratamientoreducción de dosis(reducción permanente de dosis)leucocitos-1,5 x 109/l1,0 x 109/lneutrófilosplaquetas bilirrubina ­ directa bilirrubina ­ indirecta
four week period during treatment (permanent dose reduction) 1.5 x 109/l - 0.75 x 109/l - 50 x 109/l ---5 mg/dl -